Praxis Precision Medicines, Inc. Common Stock

PRAX US74006W1080

💰
Capitalization
Small-cap

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.

Annual Performance 1
2021 2022 2023 2024 2025
-64% -88% -42% 268% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
4
🙍
Insiders
2
Person Price Shares Total Published Completed
Mastrocola Lauren
CCO
81.78
USD
5,188
Sold
424,318
USD
14/11/2024 14/11/2024
Mastrocola Lauren
CCO
81.78
USD
5,188
Sold
424,318
USD
14/11/2024 14/11/2024
Nemiroff Alex
SR OFF
80.20
USD
8,239
Sold
660,827
USD
14/11/2024 14/11/2024
Nemiroff Alex
SR OFF
80.20
USD
8,239
Sold
660,827
USD
14/11/2024 14/11/2024
Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Praxis Precision Medicines, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
10% 40% 48% 365% 0% 0% -81%
Last 52W Low 52W High All-Time Low All-Time High β
48.33 28.47 90.77 12.05 903.00
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Nemiroff Alex 2 1,321,654.92 660,827.46 14/11/2024 14/11/2024
Mastrocola Lauren 2 848,636.68 424,318.34 14/11/2024 14/11/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.